FDA Federal Register Notice: June 4, 1999 - Switzerland

[Federal Register: June 4, 1999 (Volume 64, Number 107)]
[Notices]
[Page 30038-30040]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04jn99-76]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[FDA 225-98-8003]

Agreed Minutes; Meeting Between the Food and Drug Administration
and the Health Authorities of Switzerland

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is providing notice of agreed minutes between FDA and health authorities of Switzerland. The purpose of the agreed minutes is to continue and enhance cooperation in the fields of drugs, medical devices, and biological products consistent with FDA's framework for achieving mutual recognition of good manufacturing practices inspections.

DATES: The agreement became effective August 7, 1998.

FOR FURTHER INFORMATION CONTACT: Patrick Wilson, Office of International Affairs (HFG-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4480 .

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108 (c), which states that all written agreements and understandings between FDA and others shall be published in the Federal Register, the agency is publishing notice of these agreed minutes.

Dated: May 27, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
BILLING CODE 4160-01-F
[Page 30039]
[GRAPHIC] [TIFF OMITTED] TN04JN99.000
[Page 30040]
[GRAPHIC] [TIFF OMITTED] TN04JN99.001
[FR Doc. 99-14146 Filed 6-3-99; 8:45 am]
BILLING CODE 4160-01-C